NF-κB RNAi decreases the Bax/Bcl-2 ratio and inhibits TNF-α-induced apoptosis in human alveolar epithelial cells
暂无分享,去创建一个
Li Li | Weijing Wu | Wenjie Huang | Gen Hu | Weifeng Yuan | Weifeng Li | Weifeng Li | Weijing Wu | Li Li | Wenjie Huang | Wei-feng Yuan | Gen Hu
[1] C. Gélinas,et al. Current insights into the regulation of programmed cell death by NF-kappaB. , 2006, Oncogene.
[2] M. Schmitz,et al. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. , 2007, Current medicinal chemistry.
[3] M. Hiroe,et al. Time-Dependent Alterations of VEGF and Its Signaling Molecules in Acute Lung Injury in a Rat Model of Sepsis , 2011, Inflammation.
[4] Matthew R. Jones,et al. Functions and Regulation of NF-κB RelA during Pneumococcal Pneumonia1 , 2007, The Journal of Immunology.
[5] M. Mattson,et al. NF-κB as a therapeutic target in neurodegenerative diseases , 2007 .
[6] R. Novick,et al. Lung preservation: the importance of endothelial and alveolar type II cell integrity. , 1996, The Annals of thoracic surgery.
[7] Pascal Barbry,et al. Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Schmitz,et al. NF-κB Inhibitors for the Treatment of Inflammatory Diseases and Cancer , 2007 .
[9] J. Crapo,et al. Pulmonary immunobiology and inflammation in pulmonary diseases. , 2000, American journal of respiratory and critical care medicine.
[10] E. Abraham,et al. Early alterations in neutrophil activation are associated with outcome in acute lung injury. , 2003, American journal of respiratory and critical care medicine.
[11] C Gélinas,et al. Current insights into the regulation of programmed cell death by NF-κB , 2006, Oncogene.
[12] T. Evans,et al. Epidemiology of acute lung injury , 2005, Current opinion in critical care.
[13] P. Prabhakaran. Acute respiratory distress syndrome , 2010, Indian pediatrics.
[14] H. Pahl,et al. Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.
[15] V. Popov,et al. Role of Primary Human Alveolar Epithelial Cells in Host Defense against Francisella tularensis Infection , 2007, Infection and Immunity.
[16] M. Karin,et al. Genetic dissection of antigen receptor induced-NF-kappaB activation. , 2004, Molecular immunology.
[17] A. Reimold,et al. TNFalpha as therapeutic target: new drugs, more applications. , 2002, Current drug targets. Inflammation and allergy.
[18] F. Oakley,et al. Nuclear factor-?B1: Regulation and function , 2008 .
[19] F. Frutos-Vivar,et al. Epidemiology of acute lung injury and acute respiratory distress syndrome. , 2006, Current opinion in critical care.
[20] M. Karin,et al. Genetic dissection of antigen receptor induced-NF-κB activation , 2004 .
[21] Michael Karin,et al. The IKK NF-kappa B system: a treasure trove for drug development. , 2004, Nature reviews. Drug discovery.
[22] S. Hsu,et al. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. , 1996, The American journal of pathology.
[23] I. Beletsky,et al. Cytotoxic Signal Transmission Pathways via TNF Family Receptors , 2002, Biochemistry (Moscow).
[24] Matthew R. Jones,et al. Functions and regulation of NF-kappaB RelA during pneumococcal pneumonia. , 2007, Journal of immunology.
[25] T. Evans,et al. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. , 2000, The European respiratory journal.
[26] Elisabeth Naschberger,et al. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. , 2005, Blood.
[27] O. Lesur,et al. Interleukin-2 involvement in early acute respiratory distress syndrome: Relationship with polymorphonuclear neutrophil apoptosis and patient survival , 2000, Critical care medicine.
[28] F. Oakley,et al. Nuclear factor-kappaB1: regulation and function. , 2008, The international journal of biochemistry & cell biology.
[29] Suzanne Cory,et al. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. , 2007, Current opinion in immunology.
[30] C. Gélinas,et al. To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis , 2003, Oncogene.
[31] Pingping Shen,et al. NF-kappaB and its regulation on the immune system. , 2004, Cellular & molecular immunology.
[32] C. Chung,et al. Epithelial Cell Apoptosis and Neutrophil Recruitment in Acute Lung Injury—A Unifying Hypothesis? What We Have Learned from Small Interfering RNAs , 2008, Molecular medicine.
[33] G. Kollias. TNF pathophysiology in murine models of chronic inflammation and autoimmunity. , 2005, Seminars in arthritis and rheumatism.
[34] W. Cioffi,et al. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. , 2007, American journal of respiratory and critical care medicine.
[35] R. Shenkar,et al. Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of IL-1beta. , 1999, Clinical immunology.